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Abstract: Nitrergic enteric neurons are key players of the descending inhibitory reflex of intestinal
peristalsis, therefore loss or damage of these neurons can contribute to developing gastrointestinal
motility disturbances suffered by patients worldwide. There is accumulating evidence that the
vulnerability of nitrergic enteric neurons to neuropathy is strictly region-specific and that the two
main enteric plexuses display different nitrergic neuronal damage. Alterations both in the proportion
of the nitrergic subpopulation and in the total number of enteric neurons suggest that modification of
the neurochemical character or neuronal death occurs in the investigated gut segments. This review
aims to summarize the gastrointestinal region and/or plexus-dependent pathological changes in the
number of nitric oxide synthase (NOS)-containing neurons, the NO release and the cellular and
subcellular expression of different NOS isoforms. Additionally, some of the underlying mechanisms
associated with the nitrergic pathway in the background of different diseases, e.g., type 1 diabetes,
chronic alcoholism, intestinal inflammation or ischaemia, will be discussed.
Keywords: nitric oxide synthase; nitrergic enteric neurons; enteric plexuses; microbiota–gut–brain
axis; type 1 diabetes; alcoholism; gastrointestinal inflammation
1. Introduction
In the gastrointestinal (GI) tract, as in most other organ systems, nitric oxide (NO) plays a defining
role in regulating several functions in both physiological and pathological states. NO contributes to the
maintenance of GI mucosal integrity and circulation, regulation of secretion, smooth muscle function
or mucosal inflammation [1,2]. NO, produced by neuronal NO synthase (nNOS), is one of the main
inhibitory neurotransmitters in GI smooth muscle [3,4].
The involvement of nNOS and NO pathways in enteric neuropathies was well-described in a
variety of disorders, like esophageal or internal anal sphincter achalasia, hypertrophic pyloric stenosis,
gastroparesis, Chagas’, or Hirschsprung’s disease [5]. This review will provide information about the
role of enteric neuronal NO in health and different pathological animal models with type 1 diabetes,
chronic alcoholism, intestinal inflammation, or ischaemia.
2. Enteric Neurons
Enteric neurons reside in two ganglionated plexuses of the enteric nervous system (ENS).
The myenteric plexus is situated between the longitudinal and circular muscle layers of the gut tube
and regulates the motility of these smooth muscles. The submucous plexus is embedded in the
GI submucosal layer and coordinates the absorption, secretion and circulation of the gut wall [6].
The enteric ganglia (Figure 1) contains enteric glia cells and neurons, connected by interganglionic
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segments. The number of enteric neurons is equal to the number of spinal cord neurons in the same
species [7].
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Figure 1. Representative fluorescent micrograph of a myenteric (a) and a submucous (b) ganglion 
from the duodenum of a control rat after peripherin immunolabelling. The myenteric ganglion (a) is 
bigger and contains more neurons than the submucous (b) one. Arrows show the immunolabelled 
neuronal processes in the submucous plexus. Scale bars: 20 µm. 
Intrinsic primary sensory neurons, interneurons and motoneurons are all present in the ENS, 
therefore the enteric neurons are able to form local reflex circuits in the intestinal wall and can work 
autonomously from the central nervous system [6,8]. At the same time, the ENS bidirectionally 
communicates with the central nervous system [9,10], and several data support the intimate 
connection of ENS and gut microbiota, therefore these three systems make a microbiota–gut–brain 
axis [11,12]. 
The neurochemical phenotype of enteric neurons is critical to their function [13,14]. The 
neurochemical composition of the ENS is much more diverse than the sympathetic and 
parasympathetic divisions of the autonomic nervous system. From this point of view, the ENS is 
similar to the central nervous system, since the whole range of the classical and other 
neurotransmitters are present in enteric neurons [13,15]. 
Nitrergic Enteric Neurons 
NO can be synthesized by nNOS, endothelial NOS (eNOS) and inducible NOS (iNOS) in the 
different cell types in the body. In the ENS, the major inhibitory non-adrenergic, non-cholinergic 
(NANC) neurotransmitter is endogenous NO [4,16–18]. In enteric neurons, nNOS is the 
predominant form that produces NO in a physiological state [14,19–22], but all three isoforms of the 
NOS are present in mRNA and protein levels (Figure 2) in the enteric neurons. Different 
pathological states might affect the role of the NOS isoforms in the ENS [23]. 
Figure 1. Representative fluorescent micrograph of a myenteric (a) and a submucous (b) ganglion from
the duodenum of a control rat after peripherin immunolabelling. The myenteric ganglion (a) is bigger
and contains more neurons than the submucous (b) one. Arrows show the immunolabelled neuronal
processes in the submucous plexus. Scale bars: 20 µm.
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of ENS and gut microbiota, theref re these three syst ms make a microbiota–gut–brain axis [11,12].
The neurochemical phenotype of enteric neurons is critical to their function [13,14]. The neurochemical
composition of the ENS is much more diverse than the sympathetic and parasympathetic divisions
of the autonomic nerv us system. From this point of view, the ENS is similar o the central nervous
system, since the whole range of the class al and other neurotransm tters are present in enteric
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Nitrergic Enteric Neurons
NO can be synthesized by nNOS, endothelial NOS (eNOS) and inducible NOS (iNOS) in the
different cell types in the body. In the ENS, the major inhibitory non-a renergic, non-cholinergic
(NANC) neurotransmitter is endogenous NO [4,16–18]. In enteric neurons, nNOS is the predominant
form that produces NO in a physiological state [14,19–22], but all three isoforms of the NOS are present
in mRNA and protein levels (Figure 2) in the enteric neurons. Different pathological states might affect
the role of the NOS isoforms in the ENS [23].
The proportion of the nitrergic subpopulation when co pared to the total neuronal cell number is
shown to be different in the two enteric plexuses. The nitrergic neurons account for only a few percent
of all neurons in the submucous plexus [24], while the proportion of the nitrergic myenteric neurons
(Figure 3) is significant (23–52%). This massive proportion of the nitrergic myenteric neurons can
be explained by the function of this neuron population. Most of the nitrergic myenteric neurons are
inhibitory interneurons or inhibitory motoneurons innervating the muscle layers of the alimentary
tract [14,25].
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Figure 2. Representative transmission electron micrographs of myenteric ganglia from the 
duodenum of a control rat after post-embedding immunohistochemistry, using a nNOS (a), eNOS 
(b) and iNOS (c)-specific antibody. Circles show the 18 nm gold particles conjugated to different 
NOS isoforms. Scale bars: 200 nm. 
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Figure 2. Representative transmission electron micrographs of myenteric ganglia from the duodenum
of a control rat after post-embedding immunohistochemistry, using a nNOS (a), eNOS (b) and iNOS
(c)-specific antibody. Circles show the 18 nm gold particles conjugated to different NOS isoforms. Scale
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Figure 3. Representative fluorescent micrograph of myenteric neurons from the duodenum of a 
control rat after nNOS (green)-HuCD (red) double labelling. Stars indicate neurons that are labelled 
for HuCD only, arrows point to neurons that are double-labelled for both nNOS and HuCD. Scale 
bar: 50 µm. 
3. Pathophysiology of Nitrergic Enteric Neurons 
3.1. Type 1 Diabetes 
It is well established that NOS-containing myenteric neurons are curiously susceptible to 
diabetic injuries [26–28] and impaired nitrergic innervation is accompanied by motility dysfunction 
[29]. Moreover, the nitrergic neurons located in different gut segments display strictly 
region-specific responsiveness to the diabetic state and also to immediate insulin replacement [27]. 
In the jejunum, ileum and colon of diabetic rats, both the nitrergic and total number of myenteric 
neurons were decreased assuming diabetes-related cell loss in these segments. However, in the 
duodenum of diabetic rats, the decreased number of nitrergic neurons was not accompanied by 
changes in the total number of myenteric neurons, presuming region-specific neurochemical 
modification of neurons here [27] (Table 1). Several other studies confirm diabetes-associated 
decreases of nitrergic myenteric neurons. nNOS neurons are reduced in the antrum and jejunum in 
spontaneously diabetic Bio-breeding rats [28], in the ileum of diabetic dogs [30], and in the human 
appendix [31], and reduced nNOS protein and mRNA expression were observed in the stomach of 
mice [29,32] withP2×7 receptor-mediated diabetic damage of nitrergic neurons [32]. Besides nitrergic 
neuronal damage, the diabetic animals represented delayed gastric emptying [29] and faster small 
intestinal and colonic transit compared to controls [27,33]. 
  
Figure 3. Representative fluorescent micrograph of myenteric neurons from the duodenum of a control
rat after nNOS (green)-HuCD (red) double labelling. Stars indicate neurons that are labelled for HuCD
only, arrows point to neurons that are double-labelled for both nNOS and HuCD. Scale bar: 50 µm.
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3. Pathophysiology of Nitrergic Enteric Neurons
3.1. Type 1 Diabetes
It is well established that NOS-containing myenteric neurons are curiously susceptible to diabetic
injuries [26–28] and impaired nitrergic innervation is accompanied by motility dysfunction [29].
Moreover, the nitrergic neurons located in different gut segments display strictly region-specific
responsiveness to the diabetic state and also to immediate insulin replacement [27]. In the jejunum,
ileum and colon of diabetic rats, both the nitrergic and total number of myenteric neurons were
decreased assuming diabetes-related cell loss in these segments. However, in the duodenum of
diabetic rats, the decreased number of nitrergic neurons was not accompanied by changes in the total
number of myenteric neurons, presuming region-specific neurochemical modification of neurons
here [27] (Table 1). Several other studies confirm diabetes-associated decreases of nitrergic myenteric
neurons. nNOS neurons are reduced in the antrum and jejunum in spontaneously diabetic Bio-breeding
rats [28], in the ileum of diabetic dogs [30], and in the human appendix [31], and reduced nNOS protein
and mRNA expression were observed in the stomach of mice [29,32] withP2×7 receptor-mediated
diabetic damage of nitrergic neurons [32]. Besides nitrergic neuronal damage, the diabetic animals
represented delayed gastric emptying [29] and faster small intestinal and colonic transit compared to
controls [27,33].
Table 1. Alterations in the number of nitrergic and total myenteric neurons and their consequences in
different intestinal regions of rats with type 1 diabetes or chronic alcohol consumption. The number of
total and nitrergic neurons varied differently dependent on the gut segment and also the type of disease.
The number of nitrergic myenteric neurons decreased in all investigated gut segments of diabetic
rats and also ethanol-treated animals. In diabetic rats, with the exception of the duodenum, the total
neuronal number was also decreased in the other intestinal regions; suggesting enteric neuronal loss in
these segments and neurochemical modification in the duodenum. In ethanol-treated rats, the total
number of myenteric neurons was not affected in the different gut segments proposing modification of
nNOS production in neurons. Summarized from Izbéki et al. [27] and Krecsmarik et al. [34].
Animal Models Number of MyentericNeurons Duodenum Jejunum Ileum Colon
Type 1 Diabetes [27]
Nitrergic ↓ ↓ ↓ ↓
Total Ø ↓ ↓ ↓
Pathological alteration in
nitrergic myenteric neurons
neurochemical
modification neuronal loss neuronal loss neuronal loss
Chronic Alcohol
Consumption [34]
Nitrergic ↓ ↓ ↓ ↓
Total Ø Ø Ø Ø
Pathological alteration in
nitrergic myenteric neurons
neurochemical
modification
neurochemical
modification
neurochemical
modification
neurochemical
modification
In the submucous plexus, the proportion of nNOS-immunoreactive neurons was doubled in the
ileum and tripled in the colon, but not in the duodenum of diabetic rats, while the total neuronal
number remained unchanged, suggesting neurochemical adaptation of submucous neurons [35]. These
results emphasize that the diabetic state affects the two enteric plexuses differentially.
In addition, in the microenvironment of enteric neurons, the number of eNOS-labelling gold
particles was increased in the capillary endothelium of different gut segments [36], suggesting that the
microvessels supplying to the myenteric ganglia are targets of diabetic damage in a regional manner
and may contribute to developing neuropathy in diabetes.
Sex dependency on the diabetic nitrergic dysfunction was also observed [37]; females seem to
have greater vulnerability to diabetes-related gastric impairments than males [38]. A decreased level
of tetrahydrobiopterin, a major cofactor for NO synthesis, contributes to delayed gastric emptying,
reduced pyloric nitrergic relaxation and nNOS-α protein expression in female diabetic rats [39].
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NOS-containing neurons go through a two-phase degeneration process. The decrease in axonal
nNOS expression as the hallmark of the first phase is reversible, however, causing irreversible changes,
as apoptotic loss of nitrergic neurons occurs in the second one [26,40]. In addition, progressive
accumulation of advanced glycation end products (AGEs) during diabetes seems to enhance this
apoptotic process [41]. AGEs significantly reduce the expression of nNOS and NO release in myenteric
neurons via their receptor [42]. Prevention of AGE formation by certain drugs precedes the decrease
of nNOS in diabetic rats [43] and may also help to protect against nitrergic nerve dysfunction.
Furthermore, the endogenous antioxidant defense of the gut can also be protective for nitrergic
myenteric neurons. An extensive increase in the ratio of nNOS-immunoreactive neurons colocalizing
with heme oxygenases was revealed in the ileum and colon of diabetic rats, though the nitrergic
neuronal number decreased [44], suggesting that those NOS neurons which do not colocalize with
heme oxygenases are the most damaged by diabetes [44,45].
3.2. Chronic Alcohol Consumption
The impact of chronic ethanol intake on NOS-immunoreactive myenteric neurons in various
gut regions has been investigated in our laboratory for more than a decade. The number of
nNOS-immunoreactive neurons was significantly reduced in all investigated intestinal regions after
8 weeks of ethanol consumption [34]. Since the total neuronal number in the myenteric ganglia
remained unchanged, the alteration in the number of nNOS-immunoreactive neurons means that
ethanol treatment specifically affected nNOS production (Table 1), damaging NO pathways in the
ENS and disturbing gastrointestinal motility [46]. A decreased number of nNOS-immunoreactive
neurons was also described in the murine jejunum after alcohol intake, but because it is accompanied
by an increased proportion of iNOS-immunoreactive neurons [47], the number of NO-producing
neurons remained constant. This data proposed a compensatory mechanism to restore the NOS balance.
However, using bio-imaging of individual myenteric neurons, the basal NO synthesis was significantly
enhanced after chronic alcohol consumption. Bio-imaging recordings also strengthened the elevated
NO synthesis in the enteric glial cells, smooth muscle cells and endothelial cells, indicating a general
increase in NO production in the intestinal wall [23]. In cultures, NO facilitates the protective effects of
neuronal growth factors and helps with developing neurons to resist alcohol toxicity by activating the
NO-cGMP-PKG-NFkappaB signalling pathway [48,49].
Similarly, electron microscopic study of the distribution of different NOS enzymes after ethanol
treatment revealed opposite changes in the quantity of nNOS- and eNOS-labelling gold particles not
only in the myenteric ganglia, but also in their close microenvironment [18]. While the number of nNOS
labels has fallen by more than half, eNOS labels almost doubled in the duodenal ganglia, suggesting
possible functional plasticity between NOS isoforms that might help to maintain the optimum NO
level during chronic alcohol consumption. Moreover, gut segment-specific rearrangement of NOS
isoforms in the various subcellular compartments was detected in rats after ethanol treatment [18].
3.3. Intestinal Inflammation
Although impairments of enteric neurons in different inflammatory diseases have been widely
studied [50–55], there are numerous open questions and no consensus on how the ENS is affected in
these inflammatory disorders. Intestinal inflammation affects not only the density of enteric neurons
but also their function [56,57].
Extensive damage of myenteric neurons as a distinct early event was demonstrated in the inflamed
colonic segment in different rat models despite the sustained inflammatory processes [50,58]. The rapid
influx of activated immune cells after the onset of colitis accompanied elevated NO production from
enhanced iNOS expression, which can be cytotoxic to enteric neurons. The immune-cell-mediated
neuronal loss could be blocked by iNOS inhibitors [59]. Glial cells can also enhance iNOS activity
during inflammation [60]. Brown et al. [61] observed the enhancement of glial NO levels and increased
immunoreactivity of nitrated proteins (another marker of NO concentration) colocalized with glial
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fibrillar acidic protein 48 h after the induction of colitis. Elevated nitric oxide facilitates the release of
glial adenosine triphosphate and assists with neuronal loss [61].
Among the different subpopulations of enteric neurons, the vasoactive intestinal polypeptide
(VIP)-positive and nitrergic neurons display contrary responses to gut inflammation. In the inflamed
colonic regions, the number of NOS neurons increased and the percentage of VIP neurons was
unchanged in the myenteric plexus of paediatric patients with Crohn’s disease [52]. However, in the
submucous ganglia, an increased number of VIP-immunoreactive neurons was observed, while the
number of NOS neurons was too low for quantification [52]. The regulation of nNOS expression
seems different in models of Crohn’s disease and ulcerative colitis. In 2,4,6-trinitrobenzenesulfonic
acid-induced Crohn’s disease, decreased nNOS protein and mRNA level was measured, but nNOS
levels were not altered in experimentally-induced ulcerative colitis [53]. The proportion of
nNOS-immunoreactive myenteric neurons was decreased in a stress-induced rat model of irritable bowel
syndrome with diarrhea [54] contributing to the motility dysfunction characteristic for this disease.
The activity of NOS and the generation of NO were elevated in colonic mucosal biopsies [62] as
well as rectal NO levels were markedly enhanced in active ulcerative colitis and Crohn’s disease [63].
Moreover, an increased number of mucosal nitrergic nerve fibers was revealed in the duodenum,
jejunum and descending colon of dogs with irritable bowel disease, and this increment was proportional
to the state of the disease ranging from mild to severe [64].
3.4. Ischaemic Injuries
The deleterious effects of intestinal ischemia/reperfusion (I/R) injury on enteric neurons was also
revealed in several studies. Alterations in neuronal structures or even neuronal loss were demonstrated
in humans [65] and animal models [66,67] with I/R.
However, evidence showed that the NOS-containing enteric neuronal subpopulation is more
susceptible to severe enteric neuropathies [5], like I/R, suggesting that NO from nitrergic neurons
contributes to neuronal damage. However, NO also has a neuroprotective effect: I/R resulted in more
serious damage in nNOS knock out mice, than in their wild-type counterparts [68].
Swelling and distortion of nitrergic neuronal dendrites and increased relative cell profile area of
NOS neurons was observed following I/R in the ischaemic intestinal region [69–71]. Moreover, protein
nitrosylation and translocation of Hu protein (enteric neuronal marker) from the cytoplasm to the
nuclei was also demonstrated shortly after the onset of I/R [72].
4. Conclusions
Several studies have suggested that nitrergic myenteric neurons are especially susceptible to the
development of neuropathy in diseases of the digestive tract [5,27,28,34]. Although more than 20 years
have passed since the biological properties of NO were discovered [73,74], many questions remain
unanswered concerning the role of NO in neurons both in the gut and the brain [75]. To answer these
questions, future studies will be required to investigate not only the ENS, but the microenvironment of
the enteric ganglia, the microcirculation and neuro-immune interactions of the gut, the bidirectional
communication in the gut–brain axis, and even the interactions among the microbiota, the GI tract and
the brain in health and disease.
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AGE advanced glycation end product
eNOS endothelial nitric oxide synthase
ENS enteric nervous system
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NO nitric oxide
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